Hermetica Superfood Encyclopedia
The Short Answer
Iron phosphate (FePO₄) is an inorganic iron compound delivering ferric iron (Fe³⁺) that must be reduced to ferrous iron (Fe²+) by duodenal cytochrome B (DcytB) before intestinal absorption via divalent metal transporter 1 (DMT1). Unlike ferrous sulfate, iron phosphate has extremely poor bioavailability in humans and lacks clinical evidence supporting its use as a therapeutic iron supplement.
CategoryMineral Forms
GroupMineral
Evidence LevelPreliminary
Primary Keywordiron phosphate supplement
Iron Phosphate — botanical close-up
Health Benefits
Origin & History
Natural habitat
Iron phosphate (FePO₄) is an inorganic mineral compound with a molecular weight of 150.82 g/mol that appears as a yellowish-brown to pale beige powder. It is synthetically produced through chemical reactions, typically by combining sodium phosphate with ferric chloride or ferric citrate.
“The research dossier contains no information regarding historical or traditional use of iron phosphate in any traditional medicine system or cultural context.”Traditional Medicine
Scientific Research
The research dossier contains no clinical trials, randomized controlled trials, meta-analyses, or PubMed citations evaluating iron phosphate in human subjects. The available sources focus exclusively on the compound's chemical properties and industrial applications rather than biomedical efficacy.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges are available in the provided research. The sources contain no information on standardized extract dosages, powder formulations, or clinical dosing protocols for human use. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Iron Phosphate (FePO₄) is an inorganic mineral compound with the following compositional profile: Iron (Fe³⁺) content approximately 37% by molecular weight (based on molecular weight of FePO₄ = 150.82 g/mol, with Fe contributing ~55.85 g/mol); Phosphorus (P) content approximately 20.5% by molecular weight. Contains no macronutrients (zero protein, zero fat, zero carbohydrates, zero fiber). Contains no vitamins or organic bioactive compounds. As a pure mineral salt, it provides two nutritionally relevant minerals — iron and phosphate — in fixed stoichiometric ratio. Bioavailability is notably poor: Fe³⁺ (ferric iron) in phosphate-bound form has very low gastrointestinal solubility compared to ferrous (Fe²⁺) salts such as ferrous sulfate or ferrous fumarate; absorption requires reduction to Fe²⁺ by duodenal cytochrome B (Dcytb) in the intestinal brush border, a rate-limiting step. Relative bioavailability compared to ferrous sulfate is estimated at less than 50% in most studies, with some estimates as low as 14–30% depending on gastric pH and concurrent dietary factors. Phosphate component (PO₄³⁻) is absorbed via sodium-phosphate cotransporters in the small intestine, but bioavailability from this compound is not independently characterized. No caloric value. Used primarily as a food fortification agent and pesticide (slug/snail bait) rather than a dietary supplement, meaning typical human exposure through food fortification is at trace levels (1–8 mg elemental iron per serving in fortified products).
How It Works
Mechanism of Action
Iron phosphate releases ferric iron (Fe³⁺) ions that must first be reduced to ferrous iron (Fe²⁺) by the brush-border enzyme duodenal cytochrome B (DcytB) in the proximal duodenum. Ferrous iron is then transported across the enterocyte apical membrane via divalent metal transporter 1 (DMT1, also known as SLC11A2), enters systemic circulation bound to transferrin, and is utilized for hemoglobin synthesis and incorporation into iron-dependent enzymes such as cytochrome P450 and ribonucleotide reductase. The strong phosphate binding in FePO₄ significantly limits Fe³⁺ solubilization in the gastrointestinal tract, making the reduction and absorption steps far less efficient than with soluble ferrous salts.
Clinical Evidence
No published randomized controlled trials or clinical studies have specifically evaluated iron phosphate as an oral supplement in humans for iron deficiency or iron deficiency anemia. Animal model data and in vitro dissolution studies consistently demonstrate that iron phosphate has markedly lower solubility and bioavailability compared to ferrous sulfate and ferrous fumarate, the established clinical standards. A 2004 food fortification review by Hurrell et al. classified iron phosphate as having very low relative bioavailability (~4% compared to ferrous sulfate), primarily noting its use as a food additive rather than a therapeutic supplement. The current absence of human clinical trial data means no evidence-based dosing recommendations, efficacy endpoints, or comparative effectiveness conclusions can be drawn.
Safety & Interactions
Iron phosphate is generally regarded as low-risk for acute toxicity due to its poor solubility, meaning systemic iron overload from oral intake is unlikely; however, this same property renders it ineffective as a therapeutic supplement. High-dose supplemental iron in any form can cause gastrointestinal side effects including nausea, constipation, and dark stools, though these are less commonly reported with poorly absorbed iron forms. Iron supplements broadly interact with tetracycline and fluoroquinolone antibiotics, levothyroxine, levodopa, and antacids containing calcium or magnesium, all of which can further reduce already limited iron absorption. Iron supplementation is contraindicated in hemochromatosis, hemosiderosis, and other iron overload disorders; pregnant women requiring iron supplementation should consult a physician and use clinically validated forms such as ferrous sulfate or ferric carboxymaltose.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
FePO₄Ferric phosphateIron(III) phosphatePhosphoric acid iron saltIron orthophosphateFerric orthophosphate
Frequently Asked Questions
Is iron phosphate effective for treating iron deficiency anemia?
Iron phosphate is not recommended for treating iron deficiency anemia because no human clinical trials have demonstrated its efficacy, and its relative bioavailability is approximately 4% compared to ferrous sulfate according to food fortification research. Clinically validated forms such as ferrous sulfate (standard dose 325 mg, providing ~65 mg elemental iron) or ferric carboxymaltose have robust evidence supporting their use. Individuals with diagnosed iron deficiency anemia should consult a healthcare provider for an appropriate iron formulation.
Why is iron phosphate used in food fortification if it has poor bioavailability?
Iron phosphate is added to certain fortified foods such as breakfast cereals primarily because it is organoleptically neutral — it does not cause discoloration, off-flavors, or fat oxidation the way soluble iron salts like ferrous sulfate can. Its poor solubility, while a bioavailability disadvantage, is actually valued in food manufacturing to preserve product appearance and shelf stability. Regulatory agencies such as the FDA permit its use as a food additive (GRAS status), though nutrition scientists have debated its practical contribution to dietary iron intake given its low absorption rate.
How much elemental iron does iron phosphate contain?
Iron phosphate (FePO₄) has a molecular weight of approximately 150.8 g/mol, with iron (Fe) contributing about 37% elemental iron by weight. This means a 100 mg dose of iron phosphate provides roughly 37 mg of elemental iron in theory; however, due to its poor gastrointestinal solubility, the amount of iron actually absorbed is far lower than this figure suggests and significantly less than equivalent elemental iron doses from ferrous sulfate or ferrous bisglycinate.
What is the difference between iron phosphate and ferrous sulfate?
Ferrous sulfate contains iron in the ferrous (Fe²⁺) state and is highly water-soluble, allowing direct absorption via DMT1 in the duodenum with a relative bioavailability serving as the reference standard (100%) in clinical comparisons. Iron phosphate contains ferric iron (Fe³⁺) tightly bound to phosphate, resulting in very poor water solubility and requiring enzymatic reduction by DcytB before any absorption can occur. Multiple comparative bioavailability studies classify iron phosphate at roughly 4–12% the bioavailability of ferrous sulfate, making it clinically inferior for correcting iron deficiency.
Are there any known drug interactions with iron phosphate supplements?
Although iron phosphate's poor absorption reduces the likelihood of significant systemic interactions, supplemental iron in general is known to chelate with tetracycline and fluoroquinolone antibiotics (e.g., ciprofloxacin), reducing antibiotic absorption by up to 50–90% if taken simultaneously. Iron can also impair the absorption of levothyroxine, levodopa, methyldopa, and bisphosphonates, so these medications should be taken at least 2–4 hours apart from any iron-containing product. Calcium-containing antacids and proton pump inhibitors may further reduce the minimal solubilization of iron phosphate in the stomach, making any potential absorption even more negligible.
What is the bioavailability of iron phosphate compared to other iron forms?
Iron phosphate has poor bioavailability due to its insoluble nature at physiological pH, making it a less efficient source of absorbable iron compared to ferrous forms like ferrous sulfate or ferrous bisglycinate. This is why it is primarily used in food fortification applications rather than therapeutic supplementation, where its low absorption can be offset by the larger amounts consumed through fortified foods. The exact absorption rate varies depending on food matrix and individual digestive factors, but clinical evidence specifically documenting iron phosphate bioavailability in humans is limited.
Is iron phosphate safe for long-term supplementation?
While iron phosphate is considered safe for use in food fortification due to its poor absorption profile, which limits bioavailability of excess iron, clinical safety data specific to long-term iron phosphate supplementation in humans is not well-documented in peer-reviewed literature. Iron toxicity is primarily a concern with highly bioavailable iron forms; the low absorption of iron phosphate theoretically reduces this risk but does not eliminate it in susceptible populations. Individuals with iron overload conditions should consult with a healthcare provider before using any iron supplement, including iron phosphate.
Can iron phosphate be absorbed better when taken with vitamin C or other enhancers?
Iron phosphate's poor solubility at neutral pH means that absorption enhancers like vitamin C, which work by reducing iron and increasing solubility, have limited effectiveness in improving its bioavailability compared to their effects on ferrous iron forms. The chemical structure of iron phosphate presents a fundamental challenge to enhancement strategies, as the phosphate compound remains largely insoluble even under favorable conditions. No human studies have specifically evaluated whether absorption-enhancing strategies can meaningfully improve iron phosphate uptake, making this an evidence gap in current research.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w iron-phosphate curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
